NEW YORK (GenomeWeb News) – Ocimum Biosolutions said today that it will offer genomic services on Affymetrix's platform in Europe.

Ocimum said that it will provide genomic and gene expression analysis services out of its IJsselstein facility in the Netherlands.

"With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading life science companies and research centers in Europe," Ocimum CEO Anu Acharya said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.